Sign In
Buy IDYA
$28.40
+0.530 (+1.90%)
At Close: Jun 03, 2026
Wall Street Analysts Are Bullish on Top Healthcare Picks
11:16am, Monday, 06'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on InspireMD (NSPR), IDEAYA Biosciences (IDYA) and Capricor
Wall Street Analysts Are Bullish on Top Healthcare Picks
11:15am, Monday, 06'th Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on InspireMD (NSPR
Selloff creating bargains in healthcare - Baird
05:54pm, Wednesday, 25'th Mar 2020
Stating the obvious, Baird analysts have created three lists of healthcare companies that may be worth a look considering their attractive valuations or relatively strong capitalizations amid the COVI
IDEAYA Biosciences, Inc. Reports Fourth Quarter 2019 Financial Results and Provides Business Update
10:00am, Tuesday, 24'th Mar 2020
IDEAYA Biosciences, Inc. (Nasdaq:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecu
Coronavirus Scare Supports These Biotech ETFs & Stocks
12:00am, Tuesday, 24'th Mar 2020
Stocks Analysis by Zacks Investment Research covering: S&P 500, Dow Jones Industrial Average, Gilead Sciences Inc, Biogen Inc. Read Zacks Investment Research's latest article on Investing.com
IDEAYA Biosciences, Inc. (NASDAQ: IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer, today announced that it has
Mar 18, 2020 (The Expresswire) --
Global “Hospital Acquired Infections (HAI) Diagnostics Market” Report 2020 is a comprehensive, professional report provides...
Goldman sees 143% upside in Amarin in premarket analyst action
11:26am, Friday, 13'th Mar 2020
IDEAYA Biosciences (NASDAQ:IDYA) initiated with Buy rating and $12 (192% upside) price target at Roth Capital.Menlo Therapeutics (NASDAQ:MNLO) resumed with Overweight rating and $15 (466% upside) at C
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
12:00am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 11)
Bicycle Therapeutics...
IDEAYA Biosciences, Inc. (NASDAQ: IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer, today announced an expanded
We Think IDEAYA Biosciences (NASDAQ:IDYA) Can Afford To Drive Business Growth
01:19pm, Wednesday, 19'th Feb 2020
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
IDEAYA Biosciences Announces Synthetic Lethality Research Highlights and Target Milestones for 2020
11:00am, Wednesday, 15'th Jan 2020
IDEAYA Biosciences, Inc. (NASDAQ:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer, announced key research highl
A Peek Into The Markets: US Stock Futures Gain; Jobs Report In Focus
11:31am, Friday, 10'th Jan 2020
Pre-open movers
U.S. stock futures traded higher in early pre-market trade. Data on nonfarm payrolls and unemployment rate for December will be released at 8:30 a.m. ET, while...
IDEAYA Biosciences, Inc. (NASDAQ:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics, announced that the company has entered into
